The Thai Food & Drug Administration granted Karlsruhe, Germany-based joimax full product registration.
Here are five highlights:
1. With this addition, joimax has obtained approval in 10 Asian countries.
2. The company is currently active in South Korea, China, Singapore, Indonesia, Hong Kong and Vietnam.
3. Joimax expects the product certification in Malaysia, Taiwan and Japan in 2017.
4. In 2017, joimax will begin collaborating with Seoul-based Wooridul Hospital to offer international courses in minimally invasive spine surgery.
5. Joimax develops endoscopic minimally invasive spinal surgery systems.